Status | Study |
Completed |
Study Name: Relationships Between Plasma PCSK9 Levels, LDL-cholesterol Concentrations and Lipoprotein (a) Levels in Familial Hypercholesterolemia Condition: Familial Hypercholesterolemia Date: 2014-08-22 |
Recruiting |
Study Name: Russian Familial Hypercholesterolemia Registry Condition: Familial Hypercholesterolemia Date: 2014-08-02 |
Recruiting |
Study Name: French Observatory of Familial Hypercholesterolemia in Cardiology Condition: Familial Hypercholesterolemia Date: 2013-12-06 |
Completed |
Study Name: A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia Condition: Heterozygous Familial Hypercholesterolemia Date: 2013-10-21 Interventions: Drug: Bococizumab (PF-04950615;RN316) |
Completed |
Study Name: Gene Analysis and Treatment Optimization in Chinese Homozygous Familial Hypercholesterolemia Condition: Homozygous Familial Hypercholesterolemia Date: 2013-06-07 Interventions: Genetic: Gene analysis Gene an |
Completed |
Study Name: Effect of CER-001 on Plaque Volume in Homozygous Familial Hypercholesterolemia (HoFH) Subjects Condition: Homozygous Familial Hypercholesterolemia Date: 2011-08-05 Interventions: Drug: CER-001 Biweekly infusion |
Recruiting |
Study Name: The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository Condition: Homozygous Familial Hypercholesterolemia Date: 2010-04-21 |
Completed |
Study Name: An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia Condition: Familial Hypercholesterolaemia Date: 2010-02-25 Interventions: Drug: rosuvastatin calcium 5 m |
Completed |
Study Name: Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia Condition: Familial Hypercholesterolemia Date: 2009-07-21 Interventions: Drug: lomitapide 5-60 mg po every day Other Names: |
Withdrawn |
Study Name: Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients Condition: Familial Hypercholesterolemia Date: 2008-09-11 Interventions: Drug: APL180 Drug: Placebo |